2nd NCRI AML Academy
Diagnosis and Management of Adult AML: Where are we in 2020?
Organiser: Professor Charles Craddock (Birmingham)
Co-Chairs: Dr Mike Dennis (Manchester) & Dr Steve Knapper (Cardiff)
Programme
-
Thursday 8th October - NCRI AML Academy
Chair: Professor Charles Craddock, Birmingham
-
16:00
25 years of UK AML Trials - what have we learned?
Professor Alan Burnett, POG-LR, University of Glasgow
-
16:30
AML 18, AML 19 and LI1
Professor Nigel Russell, London
Dr Mike Dennis, Manchester -
17:15
Transplant trials
Dr Victoria Potter, London
-
17:35
MRD - update and cases
Dr Richard Dillon, London
Professor Sylvie Freeman, Birmingham -
18:10
Coffee
-
18:30
AML 20
Professor Charles Craddock, Birmingham
Dr Steve Knapper, Cardiff
Dr Simon Stanworth, Oxford -
19:10
EVOLVE
Professor Paresh Vyas, Oxford
Dr Mike Dennis, Manchester -
19:40
Close of Day One
-
Friday 9th October - NCRI AML Academy
-
Plenary Session
Chairs: Dr Steve Knapper, Cardiff
Professor Sylvie Freeman, Birmingham -
09:30
Genomics in the diagnosis and management of AML in 2020
Professor Brian Huntly, Cambridge
-
09:55
Novel therapeutic strategies in relapsed AML
Professor Paresh Vyas, Oxford
Dr Victoria Potter, London -
David Grimwade Memorial Lecture
Chair: Professor Charles Craddock, Birmingham
-
10:20
Advances in the management of APML
Professor Uwe Platzbecker, Leipzig, Germany (Recorded)
-
10:50
Discussion
Live link for questions
-
11:00
Coffee
-
Transplant Roundtable Workshop
Chair: Dr Victoria Potter, London
-
11:15
Presented cases for panel discussion
Panel:
Dr Erin Hurst, Newcastle
Dr Rachel Protheroe, Bristol
Dr Eleni Tholouli, Manchester
Dr Wendy Ingram, Cardiff
Recorded case studies - live in Birmingham for interactive roundtable on stage -
12:15
Lunch
-
Plenary Session
Chair: Dr Mike Dennis, Manchester
-
13:00
Venetoclax as a potential game-changer in the management of older (and younger) adults with AML
Professor Andrew Wei, Melbourne, Australia (Recorded)
Discussion
Emerging drug and antibody targeted therapies in AML
Professor Naval Daver, MD Anderson, Texas (Recorded)Questions and discussion
Live link to speakers for Q & A -
14:25
Coffee break
-
Debate
Chair: Dr Steve Knapper, Cardiff
-
14:45
DA is still the standard induction therapy for all fit AML patients in the UK
For:
Dr Priyanka Mehta, Bristol
Dr Eleni Tholouli, ManchesterAgainst:
Professor Asim Khwaja, London
Dr Paul Cahalin, Blackpool -
15:45
Summary
Professor Charles Craddock, Birmingham
-
15:45
Close of main session
-
15:55
Nurses Session
Sarah Watmough and Kirsty Halliwell
AML Trials Unit -
16:45
Close
An error occurred trying to play the stream. Please reload the page and try again.
Close